Hepatitis C Virus
Hepatitis C virus replication is influenced by CXCL-8 and related mRNA stability
Published in Hepatitis Weekly, April 17th, 2006
"Previous studies have shown that levels of CXCL-8 are elevated in patients with chronic HCV infection and are highest in nonresponders to interferon (IFN) therapy and that CXCL-8 inhibits IFN antiviral action. CXCL-8 expression involves AU-rich elements (AREs) in 3' untranslated regions that regulate mRNA stability.
"CXCL-8 mRNA stability was, therefore, investigated in the context of HCV replication in 4 replicon cell lines, Huh7 and Huh7.5 cells, and primary human fetal hepatocytes," wrote J. Green and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-04-17)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Platelet activation in chronic hepatitis C is decreased by antiviral therapy - Hepatic Encephalopathy
Hepatic encephalopathy development predicted in severe acute hepatitis - Hepatitis B Vaccine
Hepatitis B vaccine design utilizes nanodecoy system for immunopotentiation - Hepatitis C Virus
Hepatitis C envelope 2 protein inhibits signaling for T-lymphocyte migration - Liver Fibrosis & HIV
Hepatitis B genotypes participate in liver fibrosis during coinfection with HIV - Asthma
Asthma hospitalizations increase with start of school and viral infections, study shows - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
